Metraipolis › archive › dc_71a5abb3fac1
Real-World Faricimab for Treatment-Naïve Neovascular AMD and Diabetic Macular Edema: 24-Month Outcomes from a Single-Center Pilot Cohort in South-Eastern Europe — Europe PMC PMID:42512849
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42512849
- DOI
- 10.3390/medicina62071307
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T11:04:52.429Z
- SHA-256 of the archived text
25f31445e2ec45aa353e1d6018d130e9a863877ba898cb66815e888a81421e72- Stable URL of this page
https://metraipolis.com/documento/dc_71a5abb3fac1
How to cite
Real-World Faricimab for Treatment-Naïve Neovascular AMD and Diabetic Macular Edema: 24-Month Outcomes from a Single-Center Pilot Cohort in South-Eastern Europe — Europe PMC PMID:42512849 — Europe PMC (en), https://europepmc.org/article/MED/42512849 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71a5abb3fac1 (Metraipolis archive dc_71a5abb3fac1, sha256 25f31445e2ec45aa353e1d6018d130e9a863877ba898cb66815e888a81421e72)
BibTeX
@misc{dc71a5abb3fac1,
title = {Real-World Faricimab for Treatment-Naïve Neovascular AMD and Diabetic Macular Edema: 24-Month Outcomes from a Single-Center Pilot Cohort in South-Eastern Europe — Europe PMC PMID:42512849},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42512849},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71a5abb3fac1; sha256 25f31445e2ec45aa353e1d6018d130e9a863877ba898cb66815e888a81421e72},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512849. Agents can read the archived copy with the MCP tool read_document.